| pubmed-article:3549899 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3549899 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:3549899 | lifeskim:mentions | umls-concept:C0029246 | lld:lifeskim |
| pubmed-article:3549899 | lifeskim:mentions | umls-concept:C0037744 | lld:lifeskim |
| pubmed-article:3549899 | lifeskim:mentions | umls-concept:C0022686 | lld:lifeskim |
| pubmed-article:3549899 | lifeskim:mentions | umls-concept:C0003272 | lld:lifeskim |
| pubmed-article:3549899 | lifeskim:mentions | umls-concept:C0003241 | lld:lifeskim |
| pubmed-article:3549899 | lifeskim:mentions | umls-concept:C0312418 | lld:lifeskim |
| pubmed-article:3549899 | lifeskim:mentions | umls-concept:C0013682 | lld:lifeskim |
| pubmed-article:3549899 | lifeskim:mentions | umls-concept:C1704322 | lld:lifeskim |
| pubmed-article:3549899 | lifeskim:mentions | umls-concept:C0444706 | lld:lifeskim |
| pubmed-article:3549899 | lifeskim:mentions | umls-concept:C0036667 | lld:lifeskim |
| pubmed-article:3549899 | lifeskim:mentions | umls-concept:C1521840 | lld:lifeskim |
| pubmed-article:3549899 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:3549899 | pubmed:dateCreated | 1987-4-30 | lld:pubmed |
| pubmed-article:3549899 | pubmed:abstractText | Although monoclonal antibodies (mAb) can elicit potent ADCC by human K lymphocytes, different mAb, even of the same antibody subclass or even of the same target antigen specificity, vary considerably as to their efficiency in eliciting ADCC. The extensive variability in ADCC efficiencies of murine IgG2a mAb is analyzed here. In cold-target inhibition experiments it was found that only cells coated with "ADCC-efficient" IgG2a mAb, and not "ADCC-inefficient" IgG2a mAb, inhibit K effector cell lysis of radiolabeled target cells by ADCC. This result indicates that the spatial orientation of the antibodies on the target cell membrane influences the net efficiency of ADCC reactions by affecting the efficiency of interaction between antibody and the Fc receptors (FcR) of K cells. It is proposed that a "favorable" orientation of antibodies on the target cell membrane is required for efficient ADCC reactions. This proposal is directly supported by the observation that one IgG2a mAb (20.8.4), which cross-reacts with several different H-2 alloantigens, was found to elicit efficient ADCC only when bound to certain of its possible target cell antigens. It was also observed in these studies that the organization of antibodies on a target cell membrane influences the net efficiency of ADCC reactions. It is proposed that a "favorable" antibody organization on the target cell membrane is also required for efficient ADCC reactions. This proposal is supported by the observation that certain antihuman beta 2m (anti-Hu beta 2m) IgG2a mAb, which elicit efficient ADCC lysis of human target cells, fail to elicit the lysis of murine cells having Hu beta 2m molecules coupled randomly to their external membrane surfaces. The differences in the way the Hu beta 2m was organized on the surfaces of the human cells and the murine-Hu beta 2m cell conjugates presumably caused differences in the way the bound antibodies were organized on the cell surfaces, which in turn resulted in the ADCC efficiency differences observed for the same mAb with the different target cell types. Because ADCC reactions appear to be sensitive to both the orientation and the organization of cell surface-bound antibodies, certain types of structural alterations or variations in the membrane molecules (relative to other neighboring structures on the target cell membrane) are potentially detectable by quantitative differences or variations in ADCC reactions. | lld:pubmed |
| pubmed-article:3549899 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3549899 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3549899 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3549899 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:3549899 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3549899 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3549899 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3549899 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3549899 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3549899 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3549899 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:3549899 | pubmed:issn | 0022-1767 | lld:pubmed |
| pubmed-article:3549899 | pubmed:author | pubmed-author:SearsD WDW | lld:pubmed |
| pubmed-article:3549899 | pubmed:author | pubmed-author:BurnsideS SSS | lld:pubmed |
| pubmed-article:3549899 | pubmed:author | pubmed-author:Christiaansen... | lld:pubmed |
| pubmed-article:3549899 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3549899 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:3549899 | pubmed:volume | 138 | lld:pubmed |
| pubmed-article:3549899 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3549899 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3549899 | pubmed:pagination | 2236-43 | lld:pubmed |
| pubmed-article:3549899 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:3549899 | pubmed:meshHeading | pubmed-meshheading:3549899-... | lld:pubmed |
| pubmed-article:3549899 | pubmed:meshHeading | pubmed-meshheading:3549899-... | lld:pubmed |
| pubmed-article:3549899 | pubmed:meshHeading | pubmed-meshheading:3549899-... | lld:pubmed |
| pubmed-article:3549899 | pubmed:meshHeading | pubmed-meshheading:3549899-... | lld:pubmed |
| pubmed-article:3549899 | pubmed:meshHeading | pubmed-meshheading:3549899-... | lld:pubmed |
| pubmed-article:3549899 | pubmed:meshHeading | pubmed-meshheading:3549899-... | lld:pubmed |
| pubmed-article:3549899 | pubmed:meshHeading | pubmed-meshheading:3549899-... | lld:pubmed |
| pubmed-article:3549899 | pubmed:meshHeading | pubmed-meshheading:3549899-... | lld:pubmed |
| pubmed-article:3549899 | pubmed:meshHeading | pubmed-meshheading:3549899-... | lld:pubmed |
| pubmed-article:3549899 | pubmed:meshHeading | pubmed-meshheading:3549899-... | lld:pubmed |
| pubmed-article:3549899 | pubmed:meshHeading | pubmed-meshheading:3549899-... | lld:pubmed |
| pubmed-article:3549899 | pubmed:meshHeading | pubmed-meshheading:3549899-... | lld:pubmed |
| pubmed-article:3549899 | pubmed:year | 1987 | lld:pubmed |
| pubmed-article:3549899 | pubmed:articleTitle | Apparent sensitivity of human K lymphocytes to the spatial orientation and organization of target cell-bound antibodies as measured by the efficiency of antibody-dependent cellular cytotoxicity (ADCC). | lld:pubmed |
| pubmed-article:3549899 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:3549899 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
